Compare Ishares Msci Spain ETF (EWP) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Spain ETF vs Eli Lilly And Co — how do they compare? Ishares Msci Spain ETF trades at $59.23, while Eli Lilly And Co trades at $1,172.9 (market cap $1.03T). The key difference: Eli Lilly And Co pays a 0.6% dividend while Ishares Msci Spain ETF pays none. Which is the better fit depends on your goals.
| EWP | LLY | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $60.28 | $1.24K |
52-Week Low | $43.90 | $625.65 |
Market Cap | — | $1.03T |
Enterprise Value | — | $1.07T |
Dividend Yield | — | 0.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWP trades at $59.26, showing minimal daily movement with a 0.02% gain. Technical indicators signal a bullish trend, supported by strong moving average alignment, while oscillators remain neutral. The stock exhibits tight support at $59 and resistance at $60. A dividend of $0.92 per share is scheduled for payment on June 18, 2026.
The outlook for EWP is cautiously optimistic due to bullish technicals and upcoming dividend returns. Key risks include European economic sensitivity to energy price volatility and potential interest rate impacts. Investors should monitor ECB policy decisions and regional economic performance for directional cues.
Eli Lilly (LLY) trades at $1,176.75, up 1.95% on the day, with strong fundamentals including a 31.66% net margin and consistent earnings beats. The stock shows a bearish technical signal near resistance at $1,177, while recent news highlights the $2.8 billion acquisition of AtaiBeckley to expand its mental health pipeline. Operating cash flow surged to $16.81 billion in 2025, supporting growth initiatives in obesity and Alzheimer's treatments.
Outlook remains positive with a $1.38K analyst price target and 73% buy ratings, but risks include competitive pressure in obesity drugs and high valuation multiples. Revenue growth of 65% in 2025 underscores momentum, though debt levels and acquisition integration pose challenges for sustained outperformance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ishares Msci Spain ETF
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
